CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
Halil Haldun Emiroglu
Clin Mol Hepatol. 2023;29(3):812-812.   Published online 2023 May 8    DOI: https://doi.org/10.3350/cmh.2023.0132

Excel Download

Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
Halil Haldun Emiroglu
Clinical and Molecular Hepatology. 2023;29(3):812-812   Crossref logo
Link1 Link2 Link3
Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
Joo Hyun Oh, Dong Hyun Sinn
Clinical and Molecular Hepatology. 2023;29(3):820-820   Crossref logo
Link1 Link2 Link3
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Clinical and Molecular Hepatology. 2023;29(2):367-370   Crossref logo
Link1 Link2 Link3
Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’ [Clin Mol Hepatol 2023;29:367-370]
Joo Hyun Oh, Dong Hyun Sinn
Clinical and Molecular Hepatology. 2023;29(3):828-829   Crossref logo
Link1 Link2 Link3
Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”
Chia-Ming Chu, Yun-Fan Liaw
Clinical and Molecular Hepatology. 2023;29(2):510-512   Crossref logo
Link1 Link2 Link3
Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
Jeong-Ju Yoo, Sang Gyune Kim
Clinical and Molecular Hepatology. 2023;29(2):513-515   Crossref logo
Link1 Link2 Link3
Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune tolerant phase
Bo Wan, Ruanqin Chen, Han Lin
Alimentary Pharmacology & Therapeutics. 2020;52(6):1093-1093   Crossref logo
Link1
Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune‐tolerant phase—authors' reply
Han Ah Lee, Seung Up Kim
Alimentary Pharmacology & Therapeutics. 2020;52(6):1094-1095   Crossref logo
Link1
PRO: Patients With Chronic Hepatitis B in Immune‐Tolerant Phase Should Be Treated
Jagpal Singh Klair, James Vancura, Arvind R. Murali
Clinical Liver Disease. 2020;15(1):21-24   Crossref logo
Link1 Link2 Link3 Link4
Letter: risk of hepatocellular carcinoma in immune‐tolerant phase of chronic hepatitis B
Mayur Gattani, Meghraj Ingle, Shamshersingh Chauhan, Saiprasad Lad
Alimentary Pharmacology & Therapeutics. 2020;52(5):911-912   Crossref logo
Link1 Link2
This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.